洞察市场格局
解锁药品研发情报

客服电话

400-9696-311
医药数据查询

【ChiCTR1800015324】Combining mind body physical exercise, cognitive training, and nurse-led risk factor modification to enhance cognition among older adults with mild cognitive impairment: a pilot study

基本信息
登记号

ChiCTR1800015324

试验状态

尚未开始

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2018-03-23

临床申请受理号

/

靶点

/

适应症

mild cognitive impairment

试验通俗题目

Combining mind body physical exercise, cognitive training, and nurse-led risk factor modification to enhance cognition among older adults with mild cognitive impairment: a pilot study

试验专业题目

Combining mind body physical exercise, cognitive training, and nurse-led risk factor modification to enhance cognition among older adults with mild cognitive impairment: a pilot study

申办单位信息
申请人联系人
请登录查看
申请人名称
请登录查看
联系人邮箱
请登录查看
联系人邮编

联系人通讯地址
请登录查看
临床试验信息
试验目的

The aim of this pilot study is to examine the feasibility of a complex intervention: cognitive training, mind body physical exercise, and nurse-led risk factor modification (CPR) on reducing cognitive decline among the older adults aged between 60 and 90 years with MCI when compared to health advice (HA) in primary care.

试验分类
请登录查看
试验类型

随机平行对照

试验分期

探索性研究/预试验

随机化

Computer-generated allocation sequencing will be done in blocks of eight in each intervention venue to ensure the balanced allocation of participants in each venue. This will be done by a statistician who is independent from the study.

盲法

The persons who conduct the assessments or data analyses will be blinded to group allocation.

试验项目经费来源

N/A

试验范围

/

目标入组人数

10

实际入组人数

/

第一例入组时间

2018-03-26

试验终止时间

2019-12-31

是否属于一致性

/

入选标准

Inclusion criteria for participants will be: (1) aged between 60 years and 90 years; (2) having Montreal Cognitive Assessment Hong Kong version (HK-MoCA) score within 19-21 after adjusting for years of educational (+1 point if < 6 years) suggesting MCI according to published research; and (3) being physically stable, as assessed by the study physician.;

排除标准

Exclusion criteria for participants will be: (1) a diagnosis of dementia; (2) concurrent treatment with structured cognitive training, regular physical exercises including Tai Chi or other lifestyle modifications (e.g., diet) although no restrictions will be imposed on leisure activity; (3) a past history of bipolar affective disorder or psychosis; and (4) one or more significant communicative impairments. The use of psychotropic medication; this does NOT constitute an exclusion criterion, but any use of anti-dementia and other psychotropic medications should be kept on a stable dosage for at least three months before enrolment and also throughout the study.;

研究者信息
研究负责人姓名
请登录查看
试验机构

香港中文大學醫學院賽馬會公共衞生及基層醫療學院

研究负责人电话
请登录查看
研究负责人邮箱
请登录查看
研究负责人邮编

/

联系人通讯地址
请登录查看
更多信息
获取更多临床信息查看权限
立即前往摩熵医药企业版免费查询
示例数据
<END>

最新临床资讯

摩熵医药企业版
50亿+条医药数据随时查
7天免费试用